• Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Certifications

NABL accreditation certificate (ISO/IEC 17025:2017) for testing of medical devices for bioanalytical laboratory, biologics, 09/21 to 09/23, Bengaluru

GMP manufacturing certificate for Syngene's chemical development center (S14) 12/17 to 12/22, Bengaluru

GMP manufacturing certificate for Syngene's API Manufacturing facility (MSEZ), 10/20 to 10/25, Mangaluru

Department of scientific and industrial research (DSIR) recognition for R&D units Syngene’s block S20 Bengaluru /Hyderabad Unit from 7/21 to 3/22

NABL accreditation certificate (ISO/IEC 17025:2017) for testing of medical devices for safety assessment, 12/20 to 12/22, Bengaluru

Good laboratory practices (GLP) certified by NGCMA, department of science and technology (DST), Government of India (https://dst.gov.in/ngcma) in compliance with OECD principles of GLP, 10/20 to 10/22, Bengaluru

Department of Scientific and Industrial Research (DSIR) recognition for R&D units Syngene’s Block S20 Bengaluru /Hyderabad Unit from 7/21 to 3/22

Drug Manufacturing license for Syngene's Chemical Development Center ( S14 ) 02/17 to 02/22, Bengaluru

Drug Manufacturing license for Syngene's Formulation Center (S18FC/FDC) 02/17 to 02/22, Bengaluru

NABL accreditation certificate (ISO/IEC 17025:2017) for testing of medical devices for safety assessment, 12/20 to 12/22, Bengaluru

AAALAC accredition certificate for care and use of Lab animals, 07/18 to 03/21, Bengaluru

GMP manufacturing certificate for Syngene's Formulation Center (S18FC/FDC) 02/17 to 02/22, Bengaluru

Good Laboratory Practices (GLP) certified by NGCMA, Department of Science and Technology (DST), Government of India (https://dst.gov.in/ngcma) in compliance with OECD principles of GLP, 10/20 to 10/22, Bengaluru

ISO 13485: 2016 certificate of registration for medical device quality management systems, 09/21 to 09/24, Bengaluru

ISO 9001: 2015 certificate for management systems, 08/19 to 08/22, Bengaluru

College of American pathologists (CAP)-accredited certificate for laboratories, Bengaluru

Join Syngene
Be at the cutting-edge of scientific innovation

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details